These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3100426)

  • 1. [Development of resistance in imipenem therapy in Pseudomonas aeruginosa].
    Krech T; Naumann P
    Immun Infekt; 1986 Nov; 14(6):224-6. PubMed ID: 3100426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of bronchopulmonary infections in patients during artificial respiration with imipenem/cilastatin].
    Unertl K; Lenhart FP; Ruckdeschel G
    Immun Infekt; 1986 Nov; 14(6):229-31. PubMed ID: 3100428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipenem/cilastatin treatment of multiresistant Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Pedersen SS; Pressler T; Høiby N; Bentzon MW; Koch C
    J Antimicrob Chemother; 1985 Nov; 16(5):629-35. PubMed ID: 3935639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS; Pressler T; Jensen T; Rosdahl VT; Bentzon MW; Høiby N; Koch C
    J Antimicrob Chemother; 1987 Jan; 19(1):101-7. PubMed ID: 3104273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipenem/cilastatin, an alternative treatment of pseudomonas infection in cystic fibrosis.
    Strandvik B; Malmborg AS; Bergan T; Michalsen H; Storrøsten OT; Wretlind B
    J Antimicrob Chemother; 1988 Apr; 21(4):471-80. PubMed ID: 3132441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selection of resistant variants by broad spectrum beta-lactam antibiotics: to what extent is there cross resistance between imipenem and other beta-lactam antibiotics?].
    Kahan F; Kropp H
    Immun Infekt; 1986 Nov; 14(6):232-5. PubMed ID: 3100429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Imipenem resistance in Pseudomonas aeruginosa].
    Bauernfeind A; Hörl G
    Immun Infekt; 1986 Nov; 14(6):221-4. PubMed ID: 3100425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience.
    Acar JF
    Rev Infect Dis; 1985; 7 Suppl 3():S513-7. PubMed ID: 3931199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial of imipenem/cilastatin in severely burned and infected patients.
    Culbertson GR; McManus AT; Conarro PA; McManus WF; Mason AD; Pruitt BA
    Surg Gynecol Obstet; 1987 Jul; 165(1):25-8. PubMed ID: 3109046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
    Pastel DA
    Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activity of imipenem: the first thienamycin antibiotic.
    Kropp H; Gerckens L; Sundelof JG; Kahan FM
    Rev Infect Dis; 1985; 7 Suppl 3():S389-410. PubMed ID: 3931196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem: the first thienamycin antibiotic.
    Williams RJ
    Postgrad Med J; 1986; 62 Suppl 2():75-7. PubMed ID: 3118345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
    Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
    Reutter FW
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem/cilastatin in the treatment of severe hospital infections.
    Patoia L; Menichetti F; Bucaneve G; Pasticci MB; Baratta E; Grignani F; Del Favero A
    Chemioterapia; 1988 Apr; 7(2):105-8. PubMed ID: 3165056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of imipenem against Pseudomonas and Bacteroides species.
    Williams JD
    Rev Infect Dis; 1985; 7 Suppl 3():S411-6. PubMed ID: 3931197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safe use of meropenem in a patient with a possible nonimmediate allergy to imipenem.
    Lakhal K; Lortat-Jacob B; Neukirch C; Pajot O; Wolff M
    Pharmacotherapy; 2007 Sep; 27(9):1334-8. PubMed ID: 17723087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.